Zydus Lifesciences Ltd (BOM:532321)
₹ 964.4 -8.55 (-0.88%) Market Cap: 970.41 Bil Enterprise Value: 965.67 Bil PE Ratio: 22.61 PB Ratio: 4.45 GF Score: 97/100

Cadila Healthcare Ltd to Discuss the Transaction of Zydus Cadila Entity to Sell Its India Focused Animal Health Business to Multiples Alternate Asset Management Call Transcript

May 12, 2021 / 11:00AM GMT
Release Date Price: ₹646.95 (+2.74%)
Operator

Ladies and gentlemen, good day, and welcome to the telecon of Cadila Healthcare Limited, which is scheduled to discuss sale transaction of Animal Health Established Markets undertaken by the company. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. [Akhil Gupta] from the Investor Relations team of Cadila Healthcare Limited. Thank you, and over to you, Mr. Gupta.

Unidentified Company Representative;Sharvil Pankajbhai Patel
Cadila Healthcare Limited - MD & Executive

Thank you very much. Good evening, ladies and gentlemen, and welcome to the Cadila Healthcare Limited teleconference to have a discussion on the transaction of sale of Animal Health Established Markets Undertaking. For today's call, we have with us Dr. Sharvil Patel, Managing Director; Mr. Ganesh Nayak, COO and Executive Director; Mr. Nitin Parekh, Chief Financial Officer; and Mr. Harish Sadana, Chief Strategy Officer.

With that, now I would like to turn the call over to Dr. Sharvil Patel.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot